Glucocorticoids are preferable to thionamides as first-line treatment for amiodarone-induced thyrotoxicosis due to destructive thyroiditis: A matched retrospective cohort study

Journal of Clinical Endocrinology and Metabolism

Volumn 94, Issue 10, 2009, Pages 3757-3762

  Bogazzi, Fausto ^a   Tomisti, Luca ^a   Rossi, Giuseppe ^c   Dell'Unto, Enrica ^a   Pepe, Pasquale ^c   Bartalena, Luigi ^b   Martino, Enio ^a  

^a UNIVERSITY OF PISA   (Italy)

^b UNIVERSITY OF INSUBRIA   (Italy)

^c FONDAZIONE TOSCANA GABRIELE MONASTERIO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; GLUCOCORTICOID; PREDNISONE; THIAMAZOLE; THIONAMIDE DERIVATIVE;

ADULT; AGED; AMIODARONE INDUCED THYROTOXICOSIS; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOPPLER FLOWMETRY; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; EUTHYROIDISM; FEMALE; FOLLOW UP; FREE THYROXINE INDEX; HUMAN; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RETROSPECTIVE STUDY; STATISTICAL SIGNIFICANCE; THYROIDITIS; THYROTOXICOSIS; TREATMENT OUTCOME; TREATMENT RESPONSE;

EID: 70349929506     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2009-0940     Document Type: Article

References (26)

1. Martino E, Bartalena L, Bogazzi F, Braverman LE 2001 The effects of amiodarone on the thyroid. Endocr Rev 22:240-254
2. Bartalena L, Brogioni S, Grasso L, Bogazzi F, Burelli A, Martino E 1996 Treatment of amiodarone-induced thyrotoxicosis, a difficult challenge: results of a prospective study. J Clin Endocrinol Metab 81:2930-2933 (Pubitemid 26323888)
3. Bogazzi F, Bartalena L, Gasperi M, Braverman LE, Martino E 2001 The various effects of amiodarone on thyroid function. Thyroid 11:511-519 (Pubitemid 32494600)
4. Martino E, Safran M, Aghini-Lombardi F, Rajatanavin R, Lenziardi M, Fay M, Pacchiarotti A, Aronin N, Macchia E, Haffajee C, Odoguardi L, Love J, Bigalli A, Baschieri L, Pinchera A, Braverman LE 1984 Environmental iodine intake and thyroid dysfunction during chronic amiodarone therapy. Ann Intern Med 101:28-34 (Pubitemid 14088063)
5. Eaton SE, Euinton HA, Newman CM, Weetman AP, Bennet WM 2002 Clinical experience of amiodarone-induced thyrotoxicosis over a 3-year period: role of colour-flow Doppler sonography. Clin Endocrinol (Oxf) 56:33-38
6. Tanda ML, Bogazzi F, Martino E, Bartalena L 2008 Amiodarone-induced thyrotoxicosis: something new to refine the initial diagnosis? Eur J Endocrinol 159:359-361
7. Bartalena L, Wiersinga WM, Tanda ML, Bogazzi F, Piantanida E, Lai A, Martino E 2004 Diagnosis and management of amiodarone-induced thyrotoxicosis in Europe: results of an international survey among members of the European Thyroid Association. Clin Endocrinol (Oxf) 61:494-502 (Pubitemid 39388489)
8. Diehl LA, Romaldini JH, Graf H, Bartalena L, Martino E, Albino CC, Wiersinga WM 2006 Management of amiodarone-induced thyrotoxicosis in Latin America: an electronic survey. Clin Endocrinol (Oxf) 65:433-438 (Pubitemid 44414265)
9. Tanda ML, Piantanida E, Lai A, Liparulo L, Sassi L, Bogazzi F, Wiersinga WM, Braverman LE, Martino E, Bartalena L 2008 Diagnosis and management of amiodarone-induced thyrotoxicosis: similarities and differences between North American and European thyroidologists. Clin Endocrinol (Oxf) 69:812-818
10. Bogazzi F, Bartalena L, Tomisti L, Rossi G, Tanda ML, Dell'Unto E, Aghini-Lombardi F, Martino E 2007 Glucocorticoid response in amiodarone-induced thyrotoxicosis resulting from destructive thyroiditis is predicted by thyroid volume and serum free thyroid hormone concentrations. J Clin Endocrinol Metab 92:556-562 (Pubitemid 46255295)
11. Yiu KH, Jim MH, Siu CW, Lee CH, Yuen M, Mok M, Shea YF, Fan K, Tse HF, Chow WH2009 Amiodarone-induced thyrotoxicosis is a predictor of adverse cardiovascular outcome. J Clin Endocrinol Metab 94:109-114
12. Rago T, Bencivelli W, Scutari M, Di Cosmo C, Rizzo C, Berti P, Miccoli P, Pinchera A, Vitti P 2006 The newly developed threedimensional (3D) and two-dimensional (2D) thyroid ultrasound are strongly correlated, but 2D overestimates thyroid volume in the presence of nodules. J Endocrinol Invest 29:423-426 (Pubitemid 44043358)
13. Mosteller RD 1987 Simplified calculation of body-surface area. N Engl J Med 317:1098
14. Bogazzi F, Martino E, Dell'Unto E, Brogioni S, Cosci C, Aghini- Lombardi F, Ceccarelli C, Pinchera A, Bartalena L, Braverman LE 2003 Thyroid color flow doppler sonography and radioiodine uptake in 55 consecutive patients with amiodarone-induced thyrotoxicosis. J Endocrinol Invest 26:635-640 (Pubitemid 37270694)
15. Bogazzi F, Bartalena L, Brogioni S, Mazzeo S, Vitti P, Burelli A, Bartolozzi C, Martino E 1997 Color flow Doppler sonography rapidly differentiates type I and type II amiodarone-induced thyrotoxicosis. Thyroid 7:541-545 (Pubitemid 27371790)
16. Klein JP, Logan B, Harhoff M, Andersen PK 2007 Analyzing survival curves at a fixed point in time. Stat Med 26:4505-4519 (Pubitemid 47534694)
17. Bogazzi F, Bartalena L, Cosci C, Brogioni S, Dell'Unto E, Grasso L, Aghini-Lombardi F, Rossi G, Pinchera A, Braverman LE, Martino E 2003 Treatment of type II amiodarone-induced thyrotoxicosis by either iopanoic acid or glucocorticoids: a prospective, randomized study. J Clin Endocrinol Metab 88:1999-2002 (Pubitemid 36549867)
18. Bogazzi F, Bartalena L, Dell'Unto E, Tomisti L, Rossi G, Pepe P, Tanda ML, Grasso L, Macchia E, Aghini-Lombardi F, Pinchera A, Martino E 2007 Proportion of type 1 and type 2 amiodarone-induced thyrotoxicosis has changed over a 27-year period in Italy. Clin Endocrinol (Oxf) 67:533-537 (Pubitemid 47416310)
19. Osman F, Franklyn JA, Sheppard MC, Gammage MD 2002 Successful treatment of amiodarone-induced thyrotoxicosis. Circulation 105:1275-1277
20. Davies PH, Franklyn JA, Sheppard MC 1992 Treatment of amiodarone induced thyrotoxicosis with carbimazole alone and continuation of amiodarone. Br Med J 305:224-225
21. Trip MD, Düren DR, Wiersinga WM 1994 Two cases of amiodarone- induced thyrotoxicosis successfully treated with a short course of antithyroid drugs while amiodarone was continued. Br Heart J 72:266-268
22. Newman CM, Price A, Davies DW, Gray TA, Weetman AP 1998 Amiodarone and the thyroid: a practical guide to the management of thyroid dysfunction induced by amiodarone therapy. Heart 79: 121-127 (Pubitemid 28157329)
23. Daniels GH 2001 Amiodarone-induced thyrotoxicosis. J Clin Endocrinol Metab 86:3-8
24. Farwell AP, Abend SL, Huang SK, Patwardhan NA, Braverman LE 1990 Thyroidectomy for amiodarone-induced thyrotoxicosis. JAMA 263:1526-1528
25. Franzese CB, Fan CY, Stack Jr BC 2003 Surgical management of amiodarone-induced thyrotoxicosis. Otolaryngol Head Neck Surg 129:565-570
26. Berti P, Materazzi G, Bogazzi F, Ambrosini CE, Martino E, Miccoli P 2007 Combination of minimally invasive thyroid surgery and local anesthesia associated to iopanoic acid for patients with amiodaroneinduced thyrotoxicosis and severe cardiac disorders: a pilot study. Langenbecks Arch Surg 392:709-713 (Pubitemid 47620339)